Adalimumab-induced edema of the extremities in a psoriatic patient: a case report
We report a case of extremity edema induced by adalimumab in a psoriatic patient. A 60-year-old man presented with erythema and scaling on the whole body for more than 10 years and edema on the extremities for over 2 weeks. The patient had been diagnosed with psoriasis and treated with adalimumab re...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology,
2023-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_1ff0b7c0593e4d679586b3d44ff680d0 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Xiuqiu LIN |e author |
| 700 | 1 | 0 | |a Min OU |e author |
| 700 | 1 | 0 | |a Yang LI |e author |
| 700 | 1 | 0 | |a Junjie LIN |e author |
| 700 | 1 | 0 | |a Xiaohua WANG |e author |
| 245 | 0 | 0 | |a Adalimumab-induced edema of the extremities in a psoriatic patient: a case report |
| 260 | |b editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology, |c 2023-08-01T00:00:00Z. | ||
| 500 | |a 1674-8468 | ||
| 500 | |a 10.3969/j.issn.1674-8468.2023.04.008 | ||
| 520 | |a We report a case of extremity edema induced by adalimumab in a psoriatic patient. A 60-year-old man presented with erythema and scaling on the whole body for more than 10 years and edema on the extremities for over 2 weeks. The patient had been diagnosed with psoriasis and treated with adalimumab regularly. After the third injection of adalimumab, the skin lesions were improved, but the pitting edema was gradually developed on the extremities. After one week of diuretic treatment, the edema did not completely subside, but became worse after the fourth injection. Three weeks after discontinuation of adalimumab, edema subsided. No recurrence was observed during three-month follow-up. | ||
| 546 | |a ZH | ||
| 690 | |a adalimumab | ||
| 690 | |a tnf-α inhibitor | ||
| 690 | |a drug-related adverse reaction | ||
| 690 | |a edema | ||
| 690 | |a psoriasis | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pifu-xingbing zhenliaoxue zazhi, Vol 30, Iss 4, Pp 349-351 (2023) | |
| 787 | 0 | |n http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.04.008 | |
| 787 | 0 | |n https://doaj.org/toc/1674-8468 | |
| 856 | 4 | 1 | |u https://doaj.org/article/1ff0b7c0593e4d679586b3d44ff680d0 |z Connect to this object online. |